news

recently, the 2024 beijing urban sub-center medical industry collaboration conference was held. at the conference, the "medical industry collaboration" ecological platform was officially launched. at present, there are nearly 500 pharmaceutical and health market entities in the sub-center, 621 medical institutions, and the annual revenue of the pharmaceutical industry exceeds 26 billion yuan.

make every effort to promote the construction of the "medical-industry collaboration" platform

with the theme of "ecological co-construction, medical-industrial co-win", the conference focused on two major directions: "innovation and transformation of medical technology, improvement of medical-industrial collaborative ecology" and "display of medical and health projects, promotion of medical-industrial collaborative cooperation". it discussed the policies, models, successful experiences and development trends of "medical-industrial collaboration", presented innovative medical and health projects in multiple fields, and was committed to promoting multi-party cooperation.

the conference also held a number of activities, including the launch ceremony of the "medical-industrial collaboration" ecological platform, the awarding ceremony of the medical science and technology achievement transformation service system, the release ceremony of the "medical-industrial collaborative development white paper (2024)", and the launch ceremony of the china-canada medical device innovation center, to further promote the construction of the "medical-industrial collaboration" platform in the sub-center and enhance the ecological level of the pharmaceutical and health industry.

according to the introduction, the medical industry collaborative ecological platform is positioned as a resource gathering and docking cooperation platform to support the development of medical technology innovation and the development of the pharmaceutical and health industry. with the help of internet tools, the platform will build a "411, 6816" model along the eight value chains of clinical topics, intellectual property rights, project transformation, test inspection, registration and declaration, financing and mergers and acquisitions, market application, and industrial development to attract and support the high-quality development of the pharmaceutical and health industry in the sub-center with the medical industry collaborative ecology, in accordance with the four centers of scientific research services, incubation services, industrial services, and collaborative resources, one set of operating systems, and one online platform.

the medical technology achievement transformation service system is led by the lishi international medical industry collaborative development research institute, which consists of five parts: industry coordination, technical services, professional services, cxo, and investment institutions. it involves nearly 20 professional institutions such as industry think tanks, patent agencies, law firms, engineering centers, animal experiment bases, clinical research, industrial design, testing centers, cro, cdmo, and investment funds. it is an important support for the operation of the medical industry collaborative ecological platform and a key component of medical industry collaborative work. its first batch of member units include lishi international medical industry collaborative development research institute, beijing lingfu biotechnology co., ltd., beijing medithink biotechnology co., ltd., etc.

the conference will make every effort to create a pharmaceutical and health industry ecosystem featuring "medical-industrial collaboration", launch the brand of "medical-industrial collaborative development demonstration pilot zone" in the sub-center, attract more outstanding pharmaceutical companies, medical institutions, and research institutes to join the "medical-industrial collaboration" team, and promote the construction of the sub-center's medical-industrial collaborative ecosystem and the high-quality development of the pharmaceutical and health industry through complementary advantages, resource sharing, and innovative research and development.

41 pharmaceutical companies with a production value of over 12 billion

wu kongan, member of the standing committee of the tongzhou district committee and deputy district mayor, introduced at the meeting that the sub-center takes medicine and health as its strategic engine, deeply cultivates sub-sectors, optimizes industrial layout, and strives to build an industrial city that "manufacturers" health. the sub-center targets two main directions: high-end medical devices and innovative drugs, accelerates the research and development of new drugs and medical devices, and accelerates the cultivation and development of the future health industry. in 2023, the annual income of the pharmaceutical industry in the sub-center will exceed 26 billion yuan, and the output value of 41 pharmaceutical industries above the standard will exceed 12 billion yuan, ranking fourth in the city in terms of output value, with an average annual growth rate of 14% in the past five years. there are nearly 500 market entities in the district's pharmaceutical and health market, including 7 listed companies, ranking fifth in the city. leading companies include ganli pharmaceutical, fuyuan pharmaceutical, chunli zhengda, and tiger pharmaceutical. looking to the future, in the sub-sectors of synthetic biology, gene and cell therapy, the sub-center has also forward-lookingly laid out a number of key industrialization projects such as huarong bio and northland.

taking medical-industrial collaboration as its characteristic starting point, the sub-center strives to build an innovative city that "leads" health. wu kongan said that the sub-center has now gathered 9 third-level and above hospitals, including peking university people's hospital, friendship hospital, and dongzhimen hospital. among them, anzhen hospital will officially open in october, and the capital institute of children will start construction this year. at present, the number of large hospitals in the sub-center ranks fifth in the city, and the application scenarios of medical-industrial collaborative development are more abundant. relying on medical resources such as peking university people's hospital and luhe hospital, the sub-center has established collaborative innovation platforms such as the "medical-industrial collaboration (peking university people's hospital) innovation base" and the "beijing urban sub-center medical-industrial collaborative innovation center", and has carried out close cooperation with pharmaceutical and health companies in the district.

wu kongan said that leading enterprises have driven the accelerated gathering of high-quality scientific research resources. there are now 33 research and development institutions in the field of medicine and health in the sub-center, and the innovative momentum of the coordinated development of medicine and industry is even stronger.

the sub-center also seizes the opportunity of building a national green development demonstration zone, accelerates the cultivation of national-level "green factories" and "green supply chains" in the pharmaceutical field, plans to create green development benchmark demonstration projects, and strives to form a pattern in which green development and high-quality development empower each other and advance together. positioning the rich medical resources in the pharmaceutical and health industry cluster, the sub-center plans to layout high-end health care institutions such as nursing homes and rehabilitation hospitals, and is creating a full-system service matrix of "culture, tourism, housing, health, care, and medicine".

"in the future, we will continue to focus on the theme of 'medical-industrial collaboration', improve the innovative service system, release medical application scenarios, and gather high-quality industrial projects." wu kongan said that we should give full play to the demonstration effect of being based in the sub-center, facing the beijing-tianjin-hebei region, and radiating across the country, and strive to cultivate a medical and health industry system with a more optimized layout, a more complete chain, and more distinct characteristics, and build a high ground for the coordinated development of medicine and industry.

there are 621 medical institutions in the region.

lin zhenghang, director of the tongzhou park management committee of zhongguancun science park, said at the meeting that as an important carrier of the capital's future health industry, the sub-center has a complete range of medical and health industries, with a total of 493 registered related industry entities. especially in the sub-sectors of synthetic biology, gene and cell therapy, a number of key projects such as huarong bio and northland have been deployed. at the same time, leading enterprises have accelerated the gathering of high-quality scientific research resources. there are now 33 r&d institutions in the field of medicine and health in the district, and the momentum of collaborative innovation between medicine and industry has been continuously strengthened.

lin zhenghang introduced that there are 621 medical institutions in the district, including 9 tertiary hospitals, including peking university people's hospital, friendship hospital, anzhen hospital, dongzhimen hospital, chest hospital, capital institute of children, and district maternal and child health hospital. relying on the top three famous hospitals, the district has built 3 demonstration research wards with a total of 214 beds, involving peking university people's hospital, friendship hospital, and chest hospital, and is promoting the construction of two national medical centers, peking university people's hospital and beijing university of chinese medicine dongzhimen hospital.

at present, the sub-center has sufficient space reserves for the pharmaceutical industry. there are more than 2,700 acres of available land in the pharmaceutical field, 1.03 million square meters of key business buildings, and 1.15 million square meters of professional industrial park carriers.

"we are working hard to build the medical and health industry cluster in xiang county, with a planned area of ​​13 square kilometers. we have clarified the industrial spatial layout of 'one core and four zones' (one core is the central vitality zone, and the four zones include the high-end medical intelligent manufacturing zone, the full-process health service zone, the future expansion zone, and the mizidian comprehensive development zone), improved the supporting industrial functions, and accelerated the construction of a medical and health industry system that integrates medical research, medical industry, and medical services." lin zhenghang said that the yifang health valley medical smart park was officially opened, and dozens of companies such as ottobock and lingfu bio have taken root, accumulating more than a thousand medical and health enterprise resources, and basically forming a new pattern of medical industry development that integrates biomedicine, medical devices, innovative services and other formats. in terms of innovation in spatial supply models, tongzhou park has seized the opportunity of the second batch of collective business land market entry pilot projects in the country, and the collective industrial land market entry mechanism has become more flexible, which has accelerated the pace of implementation of a number of reserve projects such as beijing oriental medical gas and yongshun guoyao.

at the same time, the sub-center played the role of the industrial guidance fund, linked up with the municipal-level 10 billion-level industrial guidance fund, and established pharmaceutical sub-funds such as sherpa and cicc northger in the field of medicine and health, with a total scale of 1.5 billion yuan.

lin zhenghang said that the zhongguancun tongzhou park management committee will go all out to serve as a good "partner" and "waiter", promote the organic integration of medical technology innovation and the development of the pharmaceutical and health industry, and help the sub-center build a "new magnetic pole" for the capital's pharmaceutical and health industry.

source: beijing urban sub-center news

author: zhao peng

process editor: u022